Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 05:06 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2CompletedINTERVENTIONAL

A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

ClinicalTrials.gov · NCT00232154 · Registry updated: 2011-04-21

Condition / research focus: Sinusitis
Sponsor: Pfizer
Countries with listed sites: United States
Registry dates and results: Start: 2005-11. Completion: 2006-06 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Zithromax (azithromycin) 500mg tablets (drug)
Endoscopic Sinus Surgery (procedure)
Blood sampling for hematology (procedure)
Blood sampling for plasma chemistry profile (procedure)
Serum pregnancy test (for women of child-bearing potential) (procedure)

Where the study takes place — 18 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Pfizer Investigational Site
Alabaster, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Hoover, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Hoover, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Fresno, California, United States
Site recruitment: Not reported
Pfizer Investigational Site
Jacksonville, Florida, United States
Site recruitment: Not reported
Pfizer Investigational Site
Miami, Florida, United States
Site recruitment: Not reported
Pfizer Investigational Site
Augusta, Georgia, United States
Site recruitment: Not reported
Pfizer Investigational Site
Elgin, Illinois, United States
Site recruitment: Not reported
Pfizer Investigational Site
Elgin, Illinois, United States
Site recruitment: Not reported
Pfizer Investigational Site
Maywood, Illinois, United States
Site recruitment: Not reported
Pfizer Investigational Site
Carrollton, Kentucky, United States
Site recruitment: Not reported
Pfizer Investigational Site
La Grange, Kentucky, United States
Site recruitment: Not reported
Pfizer Investigational Site
Louisville, Kentucky, United States
Site recruitment: Not reported
Pfizer Investigational Site
Durham, North Carolina, United States
Site recruitment: Not reported
Pfizer Investigational Site
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Efficacy of Letrozole and CC Alone in an IUI Program in Cases With Surgically Treated Minimal to Mild Endometriosis

ClinicalTrials.gov · NCT01334762 · Registry updated: 2011-04-13

Condition / research focus: Endometriosis
Sponsor: Mansoura University
Countries with listed sites: Egypt
Registry dates and results: Start: 2007-05. Completion: 2010-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole/IUI (drug)
CC/IUI (drug)

Where the study takes place — 1 listed sites

Mansoura University Hospitals,OB/GYN department
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders

ClinicalTrials.gov · NCT01205009 · Registry updated: 2011-03-02

Condition / research focus: Infertility
Sponsor: Hadassah Medical Organization
Countries with listed sites: Israel
Registry dates and results: Start: 2011-04. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ovitrelle (drug)

Where the study takes place — 1 listed sites

Hadassah Medical Center
Jerusalem, Israel, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Ultrasound for Diagnosis of Biliary Dyskinesia

ClinicalTrials.gov · NCT00737295 · Registry updated: 2010-11-16

Condition / research focus: Biliary Dyskinesia
Sponsor: Texas Tech University Health Sciences Center
Countries with listed sites: United States
Registry dates and results: Start: 2008-05. Completion: 2010-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

CCK Injection and Ultrasound (procedure)

Where the study takes place — 1 listed sites

Texas Tech University Health Sciences Center
Lubbock, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1

ClinicalTrials.gov · NCT01239706 · Registry updated: 2010-11-11

Condition / research focus: Traumatic Brain Injury
Sponsor: University of Calgary
Countries with listed sites: Canada
Registry dates and results: Start: 2010-11. Completion: 2012-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

NTx 265 (drug) — also listed as: Eprex, Ortho Biotech, Ovidrel, Serono

Where the study takes place — 1 listed sites

Foothills Medical Center
Calgary, Alberta, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Methylprednisolone Addition in IVF Treatment of Infertile Couples

ClinicalTrials.gov · NCT01220791 · Registry updated: 2010-10-14

Condition / research focus: In Vitro Fertilization
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Greece
Registry dates and results: Start: 2009-01. Completion: 2011-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

In vitro fertilization treatment for infertility (other) — also listed as: pregnancy, MEDROL, progesterone

Where the study takes place — 1 listed sites

Biogenesis
Thessaloniki, Pylaia, Greece
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Low Dose hCG in the Late Follicular Phase

ClinicalTrials.gov · NCT00750100 · Registry updated: 2010-10-11

Condition / research focus: Infertility
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2007-09. Completion: 2008-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin (drug) — also listed as: Pregnyl, NV Organon, Oss, The Netherlands
recombinant gonadotropins (drug) — also listed as: Puregon, NV Organon, Oss, The Netherlands

Where the study takes place — 1 listed sites

UZ Brussel
Laarbeeklaan 101, Brussels Capital, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles

ClinicalTrials.gov · NCT01191710 · Registry updated: 2010-09-15

Condition / research focus: Pregnancy Outcome After In Vitro Fertilization (IVF)
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Greece
Registry dates and results: Start: 2007-01. Completion: 2011-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

In vitro fertilization (other) — also listed as: IVF, pregnancy, embryo-transfer, progesterone

Where the study takes place — 1 listed sites

Biogenesis
Thessaloniki, Pylaia, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Supplementation With Human Chorionic Gonadotropin (hCG) During Controlled Ovarian Stimulation With Recombinant Follicle-stimulating Hormone (FSH) for In Vitro Fertilisation

ClinicalTrials.gov · NCT00844311 · Registry updated: 2010-08-04

Condition / research focus: Infertility
Sponsor: Copenhagen University Hospital, Rigshospitalet
Countries with listed sites: Denmark
Registry dates and results: Start: 2009-02. Completion: 2010-06 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

rFSH (drug)
human chorionic gonadotropin (drug)
human chorionic gonadotropin (drug)
human chorionic gonadotropin (drug)

Where the study takes place — 1 listed sites

The Fertility Clinic, Rigshospitalet
Copenhagen, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

ClinicalTrials.gov · NCT00648102 · Registry updated: 2010-07-26

Condition / research focus: Breast Cancer; Colorectal Cancer; Pancreatic Cancer; Bladder Cancer; Ovarian Cancer
Sponsor: Celldex Therapeutics
Countries with listed sites: United States
Registry dates and results: Start: 2006-01. Completion: 2009-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

CDX-1307 (biological)

Where the study takes place — 3 listed sites

Henry Ford Health System
Detroit, Michigan, United States
Site recruitment: Not reported
Duke University
Durham, North Carolina, United States
Site recruitment: Not reported
Carolina BioOncology Institute
Huntersville, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)

ClinicalTrials.gov · NCT00709462 · Registry updated: 2010-07-26

Condition / research focus: Breast Cancer; Colorectal Cancer; Pancreatic Cancer; Bladder Cancer; Ovarian Cancer
Sponsor: Celldex Therapeutics
Countries with listed sites: United States
Registry dates and results: Start: 2004-03. Completion: 2010-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

CDX1307 (biological)

Where the study takes place — 3 listed sites

Henry Ford Health System
Detroit, Michigan, United States
Site recruitment: Not reported
Duke University
Durham, North Carolina, United States
Site recruitment: Not reported
Carolina BioOncology Institute Cancer
Huntersville, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Synchronization of Follicle Wave Emergence and Ovarian Stimulation

ClinicalTrials.gov · NCT00439829 · Registry updated: 2010-05-25

Condition / research focus: Infertility
Sponsor: University of Saskatchewan
Countries with listed sites: Canada
Registry dates and results: Start: 2007-02. Completion: 2010-05 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonal F (drug)
Luveris (drug)
Cetrotide (drug)
hCG (drug)

Where the study takes place — 2 listed sites

Genesis Fertility Centre
Vancouver, British Columbia, Canada
Site recruitment: Not reported
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Training-induced Cerebral Reorganization in Schizophrenia

ClinicalTrials.gov · NCT00695708 · Registry updated: 2010-04-13

Condition / research focus: Schizophrenia
Sponsor: University of Konstanz
Countries with listed sites: Germany
Registry dates and results: Start: 2008-01. Completion: 2010-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Brain Fitness Program (behavioral)
Cogpack (behavioral)

Where the study takes place — 1 listed sites

University of Konstanz
Konstanz, Baden Württenberg, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Low Dose Human Chorionic Gonadotropin: Influence on the Endometrium

ClinicalTrials.gov · NCT00976651 · Registry updated: 2010-03-25

Condition / research focus: Infertility
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2009-01. Completion: 2009-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human menopausal gonadotropin (drug)

Where the study takes place — 1 listed sites

UZ Brussel
Laarbeeklaan 101, Brussels Capital, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

ClinicalTrials.gov · NCT01055990 · Registry updated: 2010-01-26

Condition / research focus: Virus Diseases; Respiratory Tract Diseases; Respiratory Tract Infections; Influenza; Orthomyxoviridae Infections
Sponsor: Shanghai Public Health Clinical Center
Countries with listed sites: China
Registry dates and results: Start: 2009-10. Completion: 2010-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

split-virion, non-adjuvanted H1N1 vaccine of 15 μg (biological)
blood fix (other)

Where the study takes place — 1 listed sites

Shanghai Public Health Clinical Center
Shanghai, Shanghai Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2UnknownINTERVENTIONAL

Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification

ClinicalTrials.gov · NCT00823121 · Registry updated: 2010-01-20

Condition / research focus: In Vitro Fertilization
Sponsor: Yazd Research & Clinical Center for Infertility
Countries with listed sites: Iran
Registry dates and results: Start: 2008-08. Completion: 2009-12 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

freezing embryos by vitrification (procedure) — also listed as: cryopreservation of embryos
fresh embryo transfers (procedure) — also listed as: embryo transfer using fresh embryos
buserelin (drug) — also listed as: suprefact
recombinant FSH (drug) — also listed as: Gonal F
human chorionic gonadotropin (pregnyl) (drug) — also listed as: pregnyl

Where the study takes place — 1 listed sites

: Research and clinical center for infertility
Yazd, Yazd Province, Iran
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)

ClinicalTrials.gov · NCT00954811 · Registry updated: 2010-01-08

Condition / research focus: Pregnancy; Pregnancy Loss
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2005-09. Completion: 2010-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

300IU rec-LH (drug)
progesterone 600mg (drug)

Where the study takes place — 1 listed sites

Centre for Reproductive Medicine, UZ Brussel
Brussels, Jette, Belgium
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Pregnancy Rates in IVF After Ovulation Triggering With Recombinant or Urinary Human Chorionic Gonadotrophin (HCG)

ClinicalTrials.gov · NCT00954265 · Registry updated: 2009-12-24

Condition / research focus: Embryonic Development; Pregnancy; VEGF
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2005-08. Completion: 2010-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

10000 IU urinary HCG (drug)
250 mcg recombinant HCG (drug)

Where the study takes place — 1 listed sites

Centre for Reproductive Medicine, UZ Brussel
Brussels, Jette, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation

ClinicalTrials.gov · NCT01029470 · Registry updated: 2009-12-10

Condition / research focus: Infertility
Sponsor: Peking University Third Hospital
Countries with listed sites: China
Registry dates and results: Start: 2009-12. Completion: 2011-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Luveris (drug) — also listed as: Gonal-f, ovidrel

Where the study takes place — 1 listed sites

Peking University third Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Incidence of Early Pregnancy Loss in Patients With Unexplained Infertility

ClinicalTrials.gov · NCT01015690 · Registry updated: 2009-11-18

Condition / research focus: Infertility
Sponsor: UMC Utrecht
Countries with listed sites: Netherlands
Registry dates and results: Start: 2006-06. Completion: 2009-03 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

UMCUtrecht
Utrecht, Utrecht, Netherlands
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 05:06 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2CompletedINTERVENTIONAL

A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

ClinicalTrials.gov · NCT00232154 · Registry updated: 2011-04-21

Condition / research focus: Sinusitis
Sponsor: Pfizer
Countries with listed sites: United States
Registry dates and results: Start: 2005-11. Completion: 2006-06 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Zithromax (azithromycin) 500mg tablets (drug)
Endoscopic Sinus Surgery (procedure)
Blood sampling for hematology (procedure)
Blood sampling for plasma chemistry profile (procedure)
Serum pregnancy test (for women of child-bearing potential) (procedure)

Where the study takes place — 18 listed sites

Pfizer Investigational Site
Alabaster, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Hoover, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Hoover, Alabama, United States
Site recruitment: Not reported
Pfizer Investigational Site
Fresno, California, United States
Site recruitment: Not reported
Pfizer Investigational Site
Jacksonville, Florida, United States
Site recruitment: Not reported
Pfizer Investigational Site
Miami, Florida, United States
Site recruitment: Not reported
Pfizer Investigational Site
Augusta, Georgia, United States
Site recruitment: Not reported
Pfizer Investigational Site
Elgin, Illinois, United States
Site recruitment: Not reported
Pfizer Investigational Site
Elgin, Illinois, United States
Site recruitment: Not reported
Pfizer Investigational Site
Maywood, Illinois, United States
Site recruitment: Not reported
Pfizer Investigational Site
Carrollton, Kentucky, United States
Site recruitment: Not reported
Pfizer Investigational Site
La Grange, Kentucky, United States
Site recruitment: Not reported
Pfizer Investigational Site
Louisville, Kentucky, United States
Site recruitment: Not reported
Pfizer Investigational Site
Durham, North Carolina, United States
Site recruitment: Not reported
Pfizer Investigational Site
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Efficacy of Letrozole and CC Alone in an IUI Program in Cases With Surgically Treated Minimal to Mild Endometriosis

ClinicalTrials.gov · NCT01334762 · Registry updated: 2011-04-13

Condition / research focus: Endometriosis
Sponsor: Mansoura University
Countries with listed sites: Egypt
Registry dates and results: Start: 2007-05. Completion: 2010-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole/IUI (drug)
CC/IUI (drug)

Where the study takes place — 1 listed sites

Mansoura University Hospitals,OB/GYN department
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders

ClinicalTrials.gov · NCT01205009 · Registry updated: 2011-03-02

Condition / research focus: Infertility
Sponsor: Hadassah Medical Organization
Countries with listed sites: Israel
Registry dates and results: Start: 2011-04. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ovitrelle (drug)

Where the study takes place — 1 listed sites

Hadassah Medical Center
Jerusalem, Israel, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Ultrasound for Diagnosis of Biliary Dyskinesia

ClinicalTrials.gov · NCT00737295 · Registry updated: 2010-11-16

Condition / research focus: Biliary Dyskinesia
Sponsor: Texas Tech University Health Sciences Center
Countries with listed sites: United States
Registry dates and results: Start: 2008-05. Completion: 2010-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

CCK Injection and Ultrasound (procedure)

Where the study takes place — 1 listed sites

Texas Tech University Health Sciences Center
Lubbock, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1

ClinicalTrials.gov · NCT01239706 · Registry updated: 2010-11-11

Condition / research focus: Traumatic Brain Injury
Sponsor: University of Calgary
Countries with listed sites: Canada
Registry dates and results: Start: 2010-11. Completion: 2012-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

NTx 265 (drug) — also listed as: Eprex, Ortho Biotech, Ovidrel, Serono

Where the study takes place — 1 listed sites

Foothills Medical Center
Calgary, Alberta, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Methylprednisolone Addition in IVF Treatment of Infertile Couples

ClinicalTrials.gov · NCT01220791 · Registry updated: 2010-10-14

Condition / research focus: In Vitro Fertilization
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Greece
Registry dates and results: Start: 2009-01. Completion: 2011-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

In vitro fertilization treatment for infertility (other) — also listed as: pregnancy, MEDROL, progesterone

Where the study takes place — 1 listed sites

Biogenesis
Thessaloniki, Pylaia, Greece
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Low Dose hCG in the Late Follicular Phase

ClinicalTrials.gov · NCT00750100 · Registry updated: 2010-10-11

Condition / research focus: Infertility
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2007-09. Completion: 2008-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin (drug) — also listed as: Pregnyl, NV Organon, Oss, The Netherlands
recombinant gonadotropins (drug) — also listed as: Puregon, NV Organon, Oss, The Netherlands

Where the study takes place — 1 listed sites

UZ Brussel
Laarbeeklaan 101, Brussels Capital, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles

ClinicalTrials.gov · NCT01191710 · Registry updated: 2010-09-15

Condition / research focus: Pregnancy Outcome After In Vitro Fertilization (IVF)
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Greece
Registry dates and results: Start: 2007-01. Completion: 2011-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

In vitro fertilization (other) — also listed as: IVF, pregnancy, embryo-transfer, progesterone

Where the study takes place — 1 listed sites

Biogenesis
Thessaloniki, Pylaia, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Supplementation With Human Chorionic Gonadotropin (hCG) During Controlled Ovarian Stimulation With Recombinant Follicle-stimulating Hormone (FSH) for In Vitro Fertilisation

ClinicalTrials.gov · NCT00844311 · Registry updated: 2010-08-04

Condition / research focus: Infertility
Sponsor: Copenhagen University Hospital, Rigshospitalet
Countries with listed sites: Denmark
Registry dates and results: Start: 2009-02. Completion: 2010-06 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

rFSH (drug)
human chorionic gonadotropin (drug)
human chorionic gonadotropin (drug)
human chorionic gonadotropin (drug)

Where the study takes place — 1 listed sites

The Fertility Clinic, Rigshospitalet
Copenhagen, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

ClinicalTrials.gov · NCT00648102 · Registry updated: 2010-07-26

Condition / research focus: Breast Cancer; Colorectal Cancer; Pancreatic Cancer; Bladder Cancer; Ovarian Cancer
Sponsor: Celldex Therapeutics
Countries with listed sites: United States
Registry dates and results: Start: 2006-01. Completion: 2009-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

CDX-1307 (biological)

Where the study takes place — 3 listed sites

Henry Ford Health System
Detroit, Michigan, United States
Site recruitment: Not reported
Duke University
Durham, North Carolina, United States
Site recruitment: Not reported
Carolina BioOncology Institute
Huntersville, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)

ClinicalTrials.gov · NCT00709462 · Registry updated: 2010-07-26

Condition / research focus: Breast Cancer; Colorectal Cancer; Pancreatic Cancer; Bladder Cancer; Ovarian Cancer
Sponsor: Celldex Therapeutics
Countries with listed sites: United States
Registry dates and results: Start: 2004-03. Completion: 2010-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

CDX1307 (biological)

Where the study takes place — 3 listed sites

Henry Ford Health System
Detroit, Michigan, United States
Site recruitment: Not reported
Duke University
Durham, North Carolina, United States
Site recruitment: Not reported
Carolina BioOncology Institute Cancer
Huntersville, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Synchronization of Follicle Wave Emergence and Ovarian Stimulation

ClinicalTrials.gov · NCT00439829 · Registry updated: 2010-05-25

Condition / research focus: Infertility
Sponsor: University of Saskatchewan
Countries with listed sites: Canada
Registry dates and results: Start: 2007-02. Completion: 2010-05 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonal F (drug)
Luveris (drug)
Cetrotide (drug)
hCG (drug)

Where the study takes place — 2 listed sites

Genesis Fertility Centre
Vancouver, British Columbia, Canada
Site recruitment: Not reported
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Training-induced Cerebral Reorganization in Schizophrenia

ClinicalTrials.gov · NCT00695708 · Registry updated: 2010-04-13

Condition / research focus: Schizophrenia
Sponsor: University of Konstanz
Countries with listed sites: Germany
Registry dates and results: Start: 2008-01. Completion: 2010-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Brain Fitness Program (behavioral)
Cogpack (behavioral)

Where the study takes place — 1 listed sites

University of Konstanz
Konstanz, Baden Württenberg, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Low Dose Human Chorionic Gonadotropin: Influence on the Endometrium

ClinicalTrials.gov · NCT00976651 · Registry updated: 2010-03-25

Condition / research focus: Infertility
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2009-01. Completion: 2009-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human menopausal gonadotropin (drug)

Where the study takes place — 1 listed sites

UZ Brussel
Laarbeeklaan 101, Brussels Capital, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

ClinicalTrials.gov · NCT01055990 · Registry updated: 2010-01-26

Condition / research focus: Virus Diseases; Respiratory Tract Diseases; Respiratory Tract Infections; Influenza; Orthomyxoviridae Infections
Sponsor: Shanghai Public Health Clinical Center
Countries with listed sites: China
Registry dates and results: Start: 2009-10. Completion: 2010-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

split-virion, non-adjuvanted H1N1 vaccine of 15 μg (biological)
blood fix (other)

Where the study takes place — 1 listed sites

Shanghai Public Health Clinical Center
Shanghai, Shanghai Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2UnknownINTERVENTIONAL

Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification

ClinicalTrials.gov · NCT00823121 · Registry updated: 2010-01-20

Condition / research focus: In Vitro Fertilization
Sponsor: Yazd Research & Clinical Center for Infertility
Countries with listed sites: Iran
Registry dates and results: Start: 2008-08. Completion: 2009-12 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

freezing embryos by vitrification (procedure) — also listed as: cryopreservation of embryos
fresh embryo transfers (procedure) — also listed as: embryo transfer using fresh embryos
buserelin (drug) — also listed as: suprefact
recombinant FSH (drug) — also listed as: Gonal F
human chorionic gonadotropin (pregnyl) (drug) — also listed as: pregnyl

Where the study takes place — 1 listed sites

: Research and clinical center for infertility
Yazd, Yazd Province, Iran
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)

ClinicalTrials.gov · NCT00954811 · Registry updated: 2010-01-08

Condition / research focus: Pregnancy; Pregnancy Loss
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2005-09. Completion: 2010-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

300IU rec-LH (drug)
progesterone 600mg (drug)

Where the study takes place — 1 listed sites

Centre for Reproductive Medicine, UZ Brussel
Brussels, Jette, Belgium
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Pregnancy Rates in IVF After Ovulation Triggering With Recombinant or Urinary Human Chorionic Gonadotrophin (HCG)

ClinicalTrials.gov · NCT00954265 · Registry updated: 2009-12-24

Condition / research focus: Embryonic Development; Pregnancy; VEGF
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2005-08. Completion: 2010-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

10000 IU urinary HCG (drug)
250 mcg recombinant HCG (drug)

Where the study takes place — 1 listed sites

Centre for Reproductive Medicine, UZ Brussel
Brussels, Jette, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation

ClinicalTrials.gov · NCT01029470 · Registry updated: 2009-12-10

Condition / research focus: Infertility
Sponsor: Peking University Third Hospital
Countries with listed sites: China
Registry dates and results: Start: 2009-12. Completion: 2011-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Luveris (drug) — also listed as: Gonal-f, ovidrel

Where the study takes place — 1 listed sites

Peking University third Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Incidence of Early Pregnancy Loss in Patients With Unexplained Infertility

ClinicalTrials.gov · NCT01015690 · Registry updated: 2009-11-18

Condition / research focus: Infertility
Sponsor: UMC Utrecht
Countries with listed sites: Netherlands
Registry dates and results: Start: 2006-06. Completion: 2009-03 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

UMCUtrecht
Utrecht, Utrecht, Netherlands
Site recruitment: Not reported

Original record, eligibility, contacts and results →